Q linea

Q linea Inventory

The Inventory of Q linea (QLINEA.ST) as of Nov 21, 2026 is 30.68 M SEK. In the previous year, Inventory was 33.27 M SEK — a change of -7.80% (lower).

Inventory

30.68 MSEK

YoY

-7.80%

Last updated:

Inventory of Q linea is 2025 30.68 M SEK. Inventory of Q linea was 2024 33.27 M SEK. It decreases by -7.80% lower compared to the previous year.

The Q linea Inventory history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Inventory
Date
Inventory
Jan 1, 2018
1.40 M SEK
Jan 1, 2019
1.00 SEK
Jan 1, 2020
12.43 M SEK
Jan 1, 2021
28.65 M SEK
Jan 1, 2022
42.28 M SEK
Jan 1, 2023
46.53 M SEK
Jan 1, 2024
33.27 M SEK
Jan 1, 2025
30.68 M SEK
The Q linea Inventory history
YEARInventoryYoY
30.68 MSEK-7.80%
33.27 MSEK-28.49%
46.53 MSEK+10.04%
42.28 MSEK+47.60%
28.65 MSEK+130.40%
12.43 MSEK+1.24 B%
1.00SEK-100.00%
1.40 MSEK-2.37%
1.44 MSEK-59.26%
3.53 MSEK—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Q linea Stock analysis

What does Q linea do? Q-linea AB develops and manufactures in-vitro diagnostic solutions for infectious diseases, focusing on antibiotic susceptibility testing. The company's core product, ASTar, is a fully-automated instrument that provides susceptibility profiles within three to six hours directly from positive blood cultures. This enables early targeted antibiotic administration for sepsis identification in hospital patients, primarily serving hospital laboratories. The firm measures bacteria's antimicrobial susceptibility using its own disposables, which are integral to the ASTar system's operation. Q-linea AB's revenue model is based on selling the ASTar instrument and its associated disposables to hospital laboratories. The company's product is specifically designed for sepsis identification in hospital settings, where rapid and accurate antibiotic susceptibility testing is critical. By providing a faster solution than traditional methods, Q-linea targets hospital labs seeking to improve patient outcomes in sepsis cases. The company operates as a holding company with a focus on developing and manufacturing IVD solutions. Its primary customers are hospital laboratories, which purchase the ASTar system and disposables to streamline their diagnostic processes. The firm's business model centers on the sale of both the instrument and the consumable disposables, creating recurring revenue streams from ongoing disposables usage. Q linea is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Q linea stock

Inventory of Q linea is 30.68 M SEK in 2025.

Inventory of Q linea changed from 33.27 M SEK to 30.68 M SEK, representing a -7.80% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Inventory Q linea since 2006 – with annual values, charts, and detailed analysis.

Inventory includes raw materials, work-in-progress, and finished goods. Efficient inventory management is crucial for profitability.

Inventory's SEK is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Inventory's Q linea historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Q linea

All Key Metrics — Q linea